These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 445963)

  • 21. Pharmacokinetics of trimetrexate (NSC 352122) in monkeys.
    Balis FM; Lester CM; Poplack DG
    Cancer Res; 1986 Jan; 46(1):169-74. PubMed ID: 2933145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-performance liquid chromatographic and enzyme-inhibition assays of methotrexate concentrations in serum from patients receiving high-dose therapy: tight binding of some methotrexate to a protein that could be dihydrofolate reductase.
    Iven H; Bartels H
    Cancer Treat Rep; 1985; 69(7-8):825-32. PubMed ID: 4016793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aerobic activated sludge transformation of methotrexate: identification of biotransformation products.
    Kosjek T; Negreira N; de Alda ML; Barceló D
    Chemosphere; 2015 Jan; 119 Suppl():S42-50. PubMed ID: 24835159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of methotrexate polyglutamates in L1210 murine leukemia cells.
    Whitehead VM
    Cancer Res; 1977 Feb; 37(2):408-12. PubMed ID: 832265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
    Matherly LH; Barlowe CK; Goldman ID
    Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of methotrexate and its impurities and metabolites with high performance liquid chromatography].
    Labat C; Mansour K; Malmary MF; Casanovas AM; Oustrin J
    J Pharm Belg; 1986; 41(1):29-34. PubMed ID: 3701565
    [No Abstract]   [Full Text] [Related]  

  • 27. Identification and quantitation of impurities in methotrexate.
    Chatterji DC; Frazier AG; Gallelli JF
    J Pharm Sci; 1978 May; 67(5):622-4. PubMed ID: 641795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liquid chromatography-tandem mass spectrometry (LC-MS-MS) method for monitoring methotrexate in the setting of carboxypeptidase-G2 therapy.
    Kumar VS; Law T; Kellogg M
    Methods Mol Biol; 2010; 603():359-63. PubMed ID: 20077087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methotrexate. I. Pharmacology and pharmacokinetics.
    Lippens RJ
    Am J Pediatr Hematol Oncol; 1984; 6(4):379-95. PubMed ID: 6398629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic methotrexate content and progression of hepatic fibrosis: preliminary findings.
    Ahern MJ; Kevat S; Hill W; Hayball PJ; Harley H; Hall PD
    Ann Rheum Dis; 1991 Jul; 50(7):477-80. PubMed ID: 1715157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using fluorescence polarization immunoassay for determination of erythrocyte methotrexate polyglutamates, a quick and easy test?
    den Boer E; Koch BC; Huisman R; de Jonge R
    Ther Drug Monit; 2014 Dec; 36(6):819-23. PubMed ID: 24739667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methotrexate concentrations in biological fluids: comparison of results obtained by radioimmunoassay and direct ligand binding radioassay.
    Virtanen R; Iisalo E; Parvinen M; Nordman E
    Acta Pharmacol Toxicol (Copenh); 1979 Apr; 44(4):296-302. PubMed ID: 433624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methotrexate and 7-hydroxymethotrexate: serum level monitoring by high-performance liquid chromatography.
    Canfell C; Sadée W
    Cancer Treat Rep; 1980 Jan; 64(1):165-9. PubMed ID: 7379052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rapid and specific radioimmunoassay for methotrexate.
    Raso V; Schreiber R
    Cancer Res; 1975 Jun; 35(6):1407-10. PubMed ID: 1079473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists.
    Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF
    Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2,4-diamino-7-hydroxy-pteridines, a new class of catabolites of methotrexate.
    Dhondt JL; Hayte JM; Millot F; Klein R; Blais JC; Pfleiderer W
    Eur J Biochem; 1991 Aug; 200(1):237-44. PubMed ID: 1879428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous determination of plasma methotrexate and 7-hydroxy methotrexate by UHPLC-MS/MS in patients receiving high-dose methotrexate therapy.
    Mei S; Shi X; Du Y; Cui Y; Zeng C; Ren X; Yu K; Zhao Z; Lin S
    J Pharm Biomed Anal; 2018 Sep; 158():300-306. PubMed ID: 29909319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid quantitation of methotrexate and its metabolites in human serum, urine and bile, using solid-phase extraction and high-performance liquid chromatography.
    Nuernberg B; Kohlbrenner M; Faulkner R; Furst DE
    J Chromatogr; 1989 Feb; 487(2):476-82. PubMed ID: 2723014
    [No Abstract]   [Full Text] [Related]  

  • 39. Separation and identification of methotrexate and its metabolites, 7-hydroxymethotrexate and polyglutamates, in human tissues by reversed-phase high-performance liquid chromatography coupled with radioimmunoassay.
    Anzai T; Jaffe N; Wang YM
    J Chromatogr; 1987 Apr; 415(2):445-9. PubMed ID: 2438295
    [No Abstract]   [Full Text] [Related]  

  • 40. Development and evaluation of an enzyme inhibition assay for methotrexate.
    Kelly MG
    Ann Clin Biochem; 1988 Sep; 25 ( Pt 5)():516-21. PubMed ID: 3232954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.